✦ LIBER ✦

Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA

✍ Scribed by Fortunato Morabito; Massimo Gentile; Stefania Ciolli; Maria T. Petrucci; Sara Galimberti; Giuseppe Mele; Antonio F. Casulli; Donato Mannina; Eugenio Piro; Graziella Pinotti; Salvatore Palmieri; Lucio Catalano; Vincenzo Callea; Massimo Offidani; Pellegrino Musto; Sara Bringhen; Luca Baldini; Patrizia Tosi; Francesco Di Raimondo; Mario Boccadoro; Antonio Palumbo; Michele Cavo

Book ID: 114794710
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 148 KB
Volume: 84
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2009.01385.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reversibility of Renal Impairment in Pat

Reversibility of Renal Impairment in Patients With Multiple Myeloma Treated With Bortezomib-Based Regimens: Identification of Predictive Factors

✍ Dimopoulos, Meletios A.; Roussou, Maria; Gavriatopoulou, Maria; Zagouri, Flora; 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 115 KB

The efficacy and safety of bortezomib an

The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimens

✍ Giulia Benevolo; Alessandra Larocca; Massimo Gentile; Patrizia Pregno; Francesca 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

Clinical efficacy of a bortezomib, cyclo

Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study

✍ Yeo-Kyeoung Kim; Sang-Kyun Sohn; Jae-Hoon Lee; Deok-Hwan Yang; Joon-Ho Moon; Jae 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 175 KB

A Prospective, Open-Label Safety and Eff

A Prospective, Open-Label Safety and Efficacy Study of Combination Treatment with Bortezomib (PS-341, Velcade™) and Melphalan in Patients with Relapsed or Refractory Multiple Myeloma

✍ Yang, Hank H.; Vescio, Robert; Schenkein, David; Berenson, James R. 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 129 KB

Safety and efficacy of bortezomib and me

Safety and efficacy of bortezomib and melphalan combination in patients with relapsed or refractory multiple myeloma: updated results of a phase 1/2 study after longer follow-up

✍ James R. Berenson; Hank H. Yang; Robert A. Vescio; Youram Nassir; Russell Mapes; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 164 KB

Safety and efficacy results from an inte

Safety and efficacy results from an international Expanded Access Programme to bortezomib for patients with relapsed and/or refractory multiple myeloma: a subset analysis of the Australian and New Zealand data of 111 patients

✍ H. Quach; N. Horvath; P. Cannell; J. R. Mikhael; B. E. Butcher; H. M. Prince 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB